跳至主要内容
临床试验/CTRI/2021/03/032466
CTRI/2021/03/032466尚未招募2 期

Effect of Granulocyte-colony stimulating factor and erythropoietin combination therapy on survival in patients of upper gastrointestinal bleed with underlying cirrhosis of liver: a parallel arm closed label randomized control trial

JIPMERpuducherry0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients above 18 years of age being evaluated for upper gastrointestinal bleed with underlying liver cirrhosis in the department of surgery, JIPMER

排除标准

  • Age <18 or >75 years, suspected autoimmune hepatitis,hepatocellular carcinoma, any focus of sepsis,multi- organ dysfunction, grade 3 or 4 hepatic encephalopathy, HIV seropositivity, pregnancy, uncontrolled hypertension, coronary artery disease,planned for liver transplantation, refusal to participate in the study

研究者

发起方
JIPMERpuducherry

相似试验